138 related articles for article (PubMed ID: 10534230)
1. Cost-effectiveness of macrolides in lower respiratory tract infections.
Dietrich ES; Voegele T; Frank U; Daschner FD
Ann Pharmacother; 1999 Oct; 33(10):1125-6. PubMed ID: 10534230
[No Abstract] [Full Text] [Related]
2. Comment: cost-effectiveness of macrolides in lower respiratory tract infections.
Renz CL; Ashraf T
Ann Pharmacother; 2000 Oct; 34(10):1206-7. PubMed ID: 11054992
[No Abstract] [Full Text] [Related]
3. [Efficacy trial in general practice substantiated. New antibiotic with strong effectiveness and tolerance].
MMW Fortschr Med; 2002 Oct; 144(42):60-1. PubMed ID: 12534000
[No Abstract] [Full Text] [Related]
4. Antibiotic sensitivity of bacteria isolated in 1998 and 1999 from patients with infections of upper airways residing in Western Pomerania.
Giedrys-Kalemba S; Kaczmarek A; Bilska I; Jezierska J; Lisowska B; Michałek-Aniko D; Ruszel B; Stelmaska-Dworak E; Jursa J
Otolaryngol Pol; 2001; 55(3):299-302. PubMed ID: 11765446
[TBL] [Abstract][Full Text] [Related]
5. [Clinical effectiveness of antibacterial drug rulicin in pyo-inflammatory diseases of the upper airways].
Luchikhin LA; Kononova NA
Vestn Otorinolaringol; 2003; (3):41-3. PubMed ID: 12847807
[No Abstract] [Full Text] [Related]
6. Resistant respiratory pathogens and extended-spectrum antibiotics.
Pichichero ME
Am Fam Physician; 1995 Nov; 52(6):1739-46. PubMed ID: 7484684
[TBL] [Abstract][Full Text] [Related]
7. [Telithromycin: a new therapeutic option for community-acquired respiratory infection].
Muñoz MJ; Azanza JR; Escolar M; Macaya A; Gil FJ
Rev Med Univ Navarra; 2002; 46(3):37-44. PubMed ID: 12685116
[No Abstract] [Full Text] [Related]
8. [Antibiotic pharmacoeconomics].
Jahnz-Rózyk K
Pol Merkur Lekarski; 2008 Nov; 25(149):437-8. PubMed ID: 19177784
[TBL] [Abstract][Full Text] [Related]
9. [New therapeutic uses of the macrolides].
Mihălţan F
Pneumologia; 2004; 53(3):100-4. PubMed ID: 16108157
[No Abstract] [Full Text] [Related]
10. Community-acquired bacterial respiratory tract infections.
Brunton S; Carmichael B; Fitzgerald M; Liu H; Varon J; Weiland D
J Fam Pract; 2005 Mar; 54(3):255-62. PubMed ID: 15755379
[No Abstract] [Full Text] [Related]
11. Blood test may lower antibiotic usage in lower respiratory tract infections.
Rollins G
Rep Med Guidel Outcomes Res; 2004 Mar; 15(6):1, 8-9. PubMed ID: 15040383
[No Abstract] [Full Text] [Related]
12. [Lower tract infections as potential indication for therapy with macrolides].
Jahnz-Rózyk K; Targowski T
Pol Merkur Lekarski; 2008 Nov; 25(149):426-8. PubMed ID: 19177781
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic prescribing and respiratory tract infections.
Dahlberg K
JAMA; 1998 Jan; 279(4):272; author reply 273. PubMed ID: 9450703
[No Abstract] [Full Text] [Related]
14. [Macrolides: indications in 1997].
Bouhour D; Peyramond D
Presse Med; 1997 Mar; 26 Suppl 2():22-6. PubMed ID: 9113049
[TBL] [Abstract][Full Text] [Related]
15. DAKOTACARE update: Antibiotic stewardship: a payer's perspective.
Amundson EP
S D Med; 2015 May; 68(5):221-2. PubMed ID: 26058262
[No Abstract] [Full Text] [Related]
16. [Bacterial flora in nontuberculous infections of the respiratory tract (findings relevant to the year 1988)].
Saviano G; Borrelli G; Cerbone V; Ferrera P; La Gala F; Cuccurullo S; Corsi G
Arch Monaldi Mal Torace; 1988; 43(6):475-85. PubMed ID: 3155011
[No Abstract] [Full Text] [Related]
17. From macrolides to ketolides: What is available for the treatment of outpatient respiratory tract infections?
Carter PL
Postgrad Med; 2002 Sep; 112(3 Suppl):18-25. PubMed ID: 19667591
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
[No Abstract] [Full Text] [Related]
19. [COPD and bacterial colonization: therapeutic implications].
Gómez J; Baños V; García Martín E
Rev Esp Quimioter; 2005 Jun; 18(2):187-91. PubMed ID: 16130042
[No Abstract] [Full Text] [Related]
20. [Physiopathology and therapy in patients with respiratory tract infections].
Saito A
Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):433-6. PubMed ID: 8315342
[No Abstract] [Full Text] [Related]
[Next] [New Search]
